Verve Therapeutics Inc (VERV)

32.16 +0.22  +0.69% NASDAQ Dec 6, 16:00 32.21 +0.05  +0.16% After-Hours: 20:00 USD

Verve Therapeutics Total Assets (Quarterly):

410.88M for Sept. 30, 2021
View 4,000+ financial data types
Browse...
View Full Chart

Total Assets (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Total Assets (Quarterly) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 410.88M
June 30, 2021 426.52M
   
March 31, 2021 158.17M
Dec. 31, 2020 78.41M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Benchmarks

Krystal Biotech Inc 451.10M
Beam Therapeutics Inc 1.157B
Qualigen Therapeutics Inc 16.40M

Total Assets (Quarterly) Range, Past 5 Years

Minimum 78.41M Dec 2020
Maximum 426.52M Jun 2021
Average 268.49M

Total Assets (Quarterly) Related Metrics

Total Liabilities (Quarterly) 25.94M
Shareholders Equity (Quarterly) 384.94M

News

Insider Buy: Verve Therapeutics
MT Newswires 12/06 12:24 ET
Verve Therapeutics' Q3 Net Loss Shrinks
MT Newswires 11/10 07:51 ET
Top IPO additions to Russell 2000 Index
SA Breaking News 09/17 10:48 ET
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.